25
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 55 Drugs for Deficiency Anemias

Chapter 55

  • Upload
    laird

  • View
    53

  • Download
    0

Embed Size (px)

DESCRIPTION

Chapter 55. Drugs for Deficiency Anemias. Anemias. Decrease in erythrocytes (RBCs) Number Size Hemoglobin content Causes Blood loss Hemolysis Bone marrow dysfunction Deficiency of substances essential for RBC formation and maturation. Red Blood Cell Development. - PowerPoint PPT Presentation

Citation preview

Page 1: Chapter  55

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Chapter 55

Drugs for Deficiency Anemias

Page 2: Chapter  55

2Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Anemias Decrease in erythrocytes (RBCs)

Number Size Hemoglobin content

Causes Blood loss Hemolysis Bone marrow dysfunction

• Deficiency of substances essential for RBC formation and maturation

Page 3: Chapter  55

3Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Red Blood Cell Development Development begins in the bone marrow Matures in the blood Evolves through four stages Healthy development requires:

Healthy bone marrow erythropoietin, iron, and other factors to support DNS synthesis

Page 4: Chapter  55

4Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Biochemistry and Physiology of Iron

Metabolic functions Fate in the body

Uptake and distribution• Uptake into mucosal cells in small intestine• Undergoes storage within mucosal cells• Undergoes binding to transferrin

Utilization and storage• Taken up by cells of the bone marrow• Taken up by the liver and other tissues• Taken up by muscle

Page 5: Chapter  55

5Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Iron in the Body Fate in the body (cont’d)

Recycling: undergoes continuous recycling Elimination: 1 mg of iron excreted each day Regulated through control of intestinal absorption

Page 6: Chapter  55

6Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Iron Deficiency Most common nutritional deficiency and

cause of nutrition-related anemia Causes Consequences Diagnosis

Page 7: Chapter  55

7Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Iron Daily requirements

Determined by rate of erythrocyte production Increased requirement during pregnancy

Dietary sources Available in foods of plant and animal origin

Page 8: Chapter  55

8Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Iron Deficiency: Causes, Consequences, and Diagnosis

Results from an imbalance in iron uptake and iron demand

Causes Pregnancy (blood volume expansion) Infancy and early childhood Chronic blood loss

Consequences Microcytic, hypochromic anemia

Page 9: Chapter  55

9Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Iron Deficiency: Causes, Consequences, and Diagnosis

Diagnosis Presence of microcytic, hypochromic erythrocytes Absence of hemosiderin in bone marrow Other laboratory work

• RBC count • Reticulocyte count• Hemoglobin• Hematocrit• Serum iron• Increased serum iron-binding capacity (IBC)

Page 10: Chapter  55

10Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Oral Iron Preparations I: Iron Salts Ferrous sulfate

Indications—drug of choice Prophylactic therapy

Adverse effects GI disturbances Staining of teeth Toxicity

Page 11: Chapter  55

11Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Oral Iron Preparations I: Iron Salts Drug interactions

Antacids Tetracycline Ascorbic acid

Other oral iron salts Ferrous gluconate, ferrous fumarate, and ferrous

aspartate Carbonyl iron

Page 12: Chapter  55

12Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Parenteral Iron Preparations I: Iron Dextran

Iron dextran (INFeD, DexFerrum) Used for patients who have experienced

intolerable or ineffective oral dosing Adverse effects

Anaphylactic reactions Hypotension Persistent pain with IM injection

Page 13: Chapter  55

13Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Parenteral Iron Preparations II: Sodium Ferric Gluconate Complex and Iron Sucrose

Alternatives to iron dextran Sodium ferric gluconate (SFGC) (Ferrlecit)

• Low risk of anaphylaxis Iron sucrose (Venofer)

• Limited to patients undergoing chronic hemodialysis• All patients must also receive erythropoietin

Most common side effects Hypotension Cramps

Ferumoxytol Approved in 2009 Iron deficiency anemia, chronic kidney disease (CKD)

Page 14: Chapter  55

14Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Iron Deficiency Treatment Guidelines Assessment Routes of administration Duration of therapy Therapeutic combinations

Page 15: Chapter  55

15Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Vitamin B12 (Cobalamin)

Essential for synthesis of DNA Absorption requires intrinsic factor Elimination takes place very slowly Daily requirement Dietary sources

Limited to microorganisms Animal products (liver, dairy products) Fortified foods

Page 16: Chapter  55

16Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Vitamin B12 (Cobalamin)

Fate in the body Absorption Distribution and storage Elimination

Page 17: Chapter  55

17Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Vitamin B12 Deficiencies: Causes, Consequences, and Diagnosis

Causes Usually result of impaired absorption Regional enteritis Celiac disease Absence of intrinsic factor

Page 18: Chapter  55

18Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Vitamin B12 Deficiencies: Causes, Consequences, and Diagnosis

Consequences Megaloblastic anemia Neurologic damage

• Demyelination of neurons GI disturbances

Diagnosis Measurement of plasma B12

Schilling test

Page 19: Chapter  55

19Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Vitamin B12 Preparations: Cyanocobalamin

Administration• Oral, parenteral, intranasal

Adverse effects • Hypokalemia

Long-term treatment• With lack of intrinsic factor, vitamin B12 therapy

lifelong• Potential hazards of folic acid

Page 20: Chapter  55

20Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Guidelines for Treating Vitamin B12 Deficiency

Route of B12 administration Treatment of moderate B12 deficiency Treatment of severe B12 deficiency Long-term treatment Potential hazard of folic acid

Page 21: Chapter  55

21Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Folic Acid Deficiency Folic acid

Essential factor for DNA synthesis• DNA replication• Cell division cannot proceed

Absorbed in the early segment of the small intestine

Significant amounts excreted daily Daily requirements Dietary sources: all foods

Page 22: Chapter  55

22Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Folic Acid Anemia: Causes and Consequences

Causes Poor diet (malnutrition and alcoholism) Malabsorption syndrome (sprue)

Consequences for developing fetus Neural tube defects (eg, spina bifida,

anencephaly) Adequate intake before conception is critical The USPSTF now recommends that women of

child-bearing age consume 400 to 800 mcg of supplemental folate each day, in addition to the folate they get in food

Page 23: Chapter  55

23Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Folic Acid Anemia:Causes and Consequences

Consequences for anyone Megaloblastic anemia Leukopenia, thrombocytopenia, injury to the oral

and GI mucosa May increase risk of colorectal cancer and

atherosclerosis

Page 24: Chapter  55

24Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Folic Acid Preparations Nomenclature Folic acid (pteroylglutamic acid)

Page 25: Chapter  55

25Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc.

Guidelines for Treating Folic Acid Deficiency

Choice of treatment modality Route of administration Prophylactic use of folic acid Treatment of severe deficiency